Identification |
Name: | Morphinan-3,6,14-triol,17-(cyclopropylmethyl)-4,5-epoxy-, (5a,6b)- |
Synonyms: | 17-(Cyclopropylmethyl)-4,5a-epoxy-3,14-dihydroxymorphinan-6b-ol; 6b-Hydroxynaltrexone; 6b-Naltrexol; b-Naltrexol |
CAS: | 49625-89-0 |
Molecular Formula: | C20H25 N O4 |
Molecular Weight: | 379.88 |
InChI: | InChI=1/C20H25NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,14-15,18,22-24H,1-2,5-10H2/t14-,15-,18+,19+,20-/m1/s1 |
Molecular Structure: |
|
Properties |
Melting Point: | 90-96?C |
Flash Point: | 291°C |
Boiling Point: | 557.5°Cat760mmHg |
Density: | 1.48g/cm3 |
Refractive index: | 1.719 |
Specification: | Light Yellow Solid usageEng:A metabolite of Naltrexone. Narcotic antagonist |
Flash Point: | 291°C |
Storage Temperature: | Refrigerator |
Usage: | A metabolite of Naltrexone. Narcotic antagonist |
Safety Data |
|
|